acebutolol has been researched along with Hypoproteinemia in 1 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
Hypoproteinemia: A condition in which total serum protein level is below the normal range. Hypoproteinemia can be caused by protein malabsorption in the gastrointestinal tract, EDEMA, or PROTEINURIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decourt, S | 1 |
| Roux, A | 1 |
| Baglin, A | 1 |
| Domart, M | 1 |
| Aubert, P | 1 |
| Flouvat, B | 1 |
| Fritel, D | 1 |
1 other study available for acebutolol and Hypoproteinemia
| Article | Year |
|---|---|
[Study of the binding of beta blockers to plasma proteins. Therapeutic consequences].
Topics: Acebutolol; Adrenergic beta-Antagonists; Blood Proteins; Dose-Response Relationship, Drug; Humans; H | 1977 |